AstraZeneca did not turn over coronavirus vaccine trial safety data to the US Food and Drug Administration (FDA) for one month, a new report claims. The late-stage study, being conducted with Oxford University, was put on hold on September 9 when a British participant was rushed to the hospital after suffering a serious reaction that…
AstraZeneca took ONE MONTH to give the FDA vaccine trial data after the study was paused — The California Sun
Advertisements